Profile for European Patent Office Patent: 2528602
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2528602
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BELRAPZO | bendamustine hydrochloride |
| ⤷ Start Trial | Jan 28, 2031 | Eagle Pharms | BENDEKA | bendamustine hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
